Christy, Inc. v. United States

CourtUnited States Court of Federal Claims
DecidedJanuary 29, 2019
Docket18-657
StatusPublished

This text of Christy, Inc. v. United States (Christy, Inc. v. United States) is published on Counsel Stack Legal Research, covering United States Court of Federal Claims primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Christy, Inc. v. United States, (uscfc 2019).

Opinion

In the United States Court of Federal Claims No. 18-657C (Filed: January 29, 2019)

************************************* CHRISTY, INC., * * Patents; Inter Partes Review; Leahy-Smith Plaintiff, * America Invents Act; RCFC 12(b)(1); * RCFC 12(b)(6); Takings Clause; Patents as v. * Property; Public Franchise; Breach of * Contract; Patents as Contracts; Illegal THE UNITED STATES, * Exaction * Defendant. * *************************************

Timothy C. Davis, Birmingham, AL, for plaintiff.

Jenna Munnelly, United States Department of Justice, Washington, DC, for defendant.

OPINION AND ORDER

SWEENEY, Chief Judge

In this case, plaintiff Christy, Inc. (“Christy”) contends that the invalidation of eighteen claims asserted in one of its patents effected a taking without just compensation in violation of the Takings Clause of the Fifth Amendment to the United States Constitution (“Takings Clause”), a breach of contract, and an illegal exaction. The invalidation of those claims occurred when the Patent Trial and Appeal Board of the United States Patent and Trademark Office issued a final written decision at the conclusion of an inter partes review of Christy’s patent. Defendant moves to dismiss Christy’s complaint for lack of subject-matter jurisdiction pursuant to Rule 12(b)(1) of the Rules of the United States Court of Federal Claims (“RCFC”) and, alternatively, for failure to state a claim upon which this court can grant relief pursuant to RCFC 12(b)(6). As explained below, patents are neither contracts nor property for Takings Clause purposes. Further, the Patent and Trademark Office did not illegally exact Christy’s funds. Therefore, the court grants defendant’s motion and dismisses Christy’s amended complaint.

I. BACKGROUND

A. Obtaining a Patent

Article I, Section 8, Clause 8 of the United States Constitution provides that “Congress shall have Power . . . To promote the Progress of Science and useful Arts, by securing for limited Times to Authors and Inventors the exclusive Right to their respective Writings and Discoveries.”1 Congress exercises this authority through title thirty-five of the United States Code. See generally Pub. L. No. 593, ch. 950, 66 Stat. 792 (1952). Specifically, Congress has provided that “[w]hoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements” of title thirty-five. 35 U.S.C. § 101 (2012). The claimed invention must be novel; a person is not entitled to a patent if there is prior art regarding the claimed invention, i.e., if “the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public” prior to the filing of the patent application. Id. § 102. Further, the claimed invention must be nonobvious; even if a claimed invention is novel, a person is not entitled to a patent if “the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains.” Id. § 103.

Patent applications must be submitted to the Patent and Trademark Office in writing and include a specification, a drawing, an oath or declaration, and the required fees. Id. § 111(a); see also id. § 41(a) (listing general patent fees). The specification

shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. . . . The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention.

Id. § 112(a)-(b). Patent applications are then examined, and the Director of the Patent and Trademark Office (the “Director”) “shall issue a patent” if, upon such examination, “it appears that the applicant is entitled to a patent.” Id. § 131. Rejected or deficient applications are reexamined upon request of the applicant. Id. § 132. The applicant may appeal adverse decisions to the Patent Trial and Appeal Board upon payment of the appeal fee. Id. § 134; see also id. § 41(a)(6) (listing appeal fees). Decisions of the Patent Trial and Appeal Board are subject to appellate review in the United States Court of Appeals for the Federal Circuit

1 The facts in this section—which are undisputed for the purpose of resolving defendant’s motion to dismiss—derive from the complaint, the parties’ submissions (including attached exhibits), and matters of which the court may take judicial notice pursuant to Rule 201 of the Federal Rules of Evidence. See Rocky Mountain Helium, LLC v. United States, 841 F.3d 1320, 1325-26 (Fed. Cir. 2016).

-2- (“Federal Circuit”).2 Id. § 141(a)-(b). Patents are generally valid for twenty years and “grant to the patentee, [and] his heirs or assigns, . . . the right to exclude others from making, using, offering for sale, or selling the invention throughout the United States or importing the invention into the United States.”3 Id. § 154(a)(1)-(2).

B. Terminating a Patent

A patent owner’s interest in a patent may be terminated in multiple ways.

First, a patent owner may terminate its interest in a patent by assignment. An interest in a patent (whether in the application stage or having already been granted) may be transferred via written instrument. Id. § 261.

Second, the Patent and Trademark Office may terminate a patent based on failure to pay fees. See id. § 41(b)(2), (c)(1). Once a patent is granted, its owner must periodically pay fees for the Patent and Trademark Office to “maintain[] in force” the underlying patent; these fees are known as maintenance fees. Id. § 41(b)(1).

Third, a patent owner may have a patent (or one or more of its claims) declared invalid in judicial proceedings. See id. § 282(c). A patent owner whose patent is infringed may seek available remedies by filing a civil action in federal district court.4 Id. § 281; 28 U.S.C. § 1338 (2012); see also 35 U.S.C. § 271 (describing acts that constitute patent infringement). If the federal government is the alleged infringer, the patent owner must sue in the United States Court of Federal Claims (“Court of Federal Claims”). 28 U.S.C. § 1498(a). A defendant in a patent infringement action may assert prior commercial use, noninfringement, absence of liability for infringement, unenforceability, or invalidity of the patent itself or one or more of its claims. 35 U.S.C. §§ 273(a), 282(b). A patent, and each claim thereof, is “presumed valid,” and a party asserting invalidity has the burden of establishing such invalidity by clear and convincing evidence.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Schillinger v. United States
155 U.S. 163 (Supreme Court, 1894)
United States v. Berdan Fire-Arms Manufacturing Co.
156 U.S. 552 (Supreme Court, 1895)
Crown Die & Tool Co. v. Nye Tool & MacHine Works
261 U.S. 24 (Supreme Court, 1923)
United States v. Sherwood
312 U.S. 584 (Supreme Court, 1941)
Graham v. John Deere Co. of Kansas City
383 U.S. 1 (Supreme Court, 1966)
United States v. King
395 U.S. 1 (Supreme Court, 1969)
Board of Regents of State Colleges v. Roth
408 U.S. 564 (Supreme Court, 1972)
Scheuer v. Rhodes
416 U.S. 232 (Supreme Court, 1974)
United States v. Testan
424 U.S. 392 (Supreme Court, 1976)
Ruckelshaus v. Monsanto Co.
467 U.S. 986 (Supreme Court, 1984)
Hercules, Inc. v. United States
516 U.S. 417 (Supreme Court, 1996)
Ruhrgas Ag v. Marathon Oil Co.
526 U.S. 574 (Supreme Court, 1999)
United States v. Cotton
535 U.S. 625 (Supreme Court, 2002)
Arbaugh v. Y & H Corp.
546 U.S. 500 (Supreme Court, 2006)
Tellabs, Inc. v. Makor Issues & Rights, Ltd.
551 U.S. 308 (Supreme Court, 2007)
Erickson v. Pardus
551 U.S. 89 (Supreme Court, 2007)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
ARCAM PHARMACEUTICAL CORP. v. Faria
513 F.3d 1 (First Circuit, 2007)

Cite This Page — Counsel Stack

Bluebook (online)
Christy, Inc. v. United States, Counsel Stack Legal Research, https://law.counselstack.com/opinion/christy-inc-v-united-states-uscfc-2019.